1. Home
  2. Products
  3. Cell Line

ACE2 enhanced BEWO Cell Line (CAT#: VCeL-Wyb041)

  • Product Overview
  • ACE2 enhanced human choriocarcinoma cell
  • Quantity
  • 3-5×106 cells/ml
  • Target
  • SARS-CoV-2
  • Applications
  • Effective tools for studying COVID-19 drugs and vaccines.
  • Cell Type
  • ACE2 Enhanced Cell Line
  • Organism
  • BEWO cells
  • Growth Properties
  • Adherent
  • Fluid Renewal
  • 2 to 3 times / week
  • Form
  • Frozen Cryovial
  • Biosafety Level
  • 1
  • Alternative Names
  • ACE2 enhanced BEWO Cell Line
Related products
· hACE2-NIH-3T3 Stable Cell Line (CAT#: VCeL-Wyb026)
· hACE2-CHO Stable Cell-line (CAT#: VCeL-Wyb019)
· ACE2 enhanced HepG2 Cell Line (CAT#: VCeL-Wyb043)
· hACE2-CHO-K1 Stable Cell Line (CAT#: VCeL-Wyb027)
· ACE2-TMPRSS2 co-enhanced RT4 Cell Line (CAT#: VCeL-Wyb051)
· Spike-CHO Stable Cell Line (CAT#: VCeL-Wyb030)
· ACE2 enhanced NB-4 Cell Line (CAT#: VCeL-Wyb044)
· ΔTMPRSS2-HeLa Cell Line (CAT#: VCeL-Wyb038)
Online Inquiry For Research Use Only. We do not provide direct services or products for patients.


Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.




Inquiry

Top
Inquiry Basket